Patients feel benefit as drug prices cut

    By Wang Xiaodong | China Daily | Updated: 2020-01-14 04:07
    Share
    Share - WeChat
    Li Ziyu (right), an expert at the Beijing Cancer Hospital, explains treatment to a patient in Cangzhou, Hebei province, as part of cooperation between large hospitals in Beijing and smaller ones outside of the city. [Photo/Xinhua]

    Health: Reimbursement list widens

    The negotiations resulted in the average price of drugs being reduced by just over 60 percent, according to the health administration. Agreements were also renewed for another 27 drugs already on the list, with an average price cut of 26 percent, the administration said. The expanded list took effect on Jan 1.

    These drugs have proved effective in treating cancer and other serious illnesses, such as hepatitis, diabetes, tuberculosis, and both rare and cardiovascular diseases.

    Most of the drugs have only been on the market for just two years. Their inclusion on the reimbursement list will further reduce patients' financial burden, according to the administration.

    Xiong Xianjun, head of medical services supervision at the administration, said, "The negotiations were the largest of their kind in China in recent years, resulting in many achievements, including a significant fall in drug prices.

    "Some imported drugs will be sold at the lowest prices in the world on the Chinese mainland. Coupled with reimbursement by healthcare insurance funds, it is estimated that the price drop will reduce patients' spending more than 80 percent in general, and by over 95 percent in a few cases."

    Only a few years ago, many imported patented drugs, including those to treat cancer, cost more in China than in many other countries due to factors including higher tariffs, costs incurred by middlemen and a lack of domestic competitors. There was no price negotiation system, and many of the drugs were not included in the basic healthcare insurance program for reimbursement.

    This placed a great financial burden on millions of cancer patients, with many of them having to buy cheaper generic drugs from countries such as India through the internet, posing potential health and legal risks.

    Cancer cases and other chronic illnesses such as cardiovascular disease are rising. According to the National Cancer Institute, more than 10,000 people a day in China are diagnosed with cancer due to the aging population and unhealthy lifestyles. As a result, medical bills are expected to rise rapidly in the coming years.

    Last year, Dying to Survive, a movie based on real-life events centering on the dilemma facing many leukemia patients, sparked heated public debate, with calls being made for accelerated efforts to improve patients' access to expensive patented drugs.

    |<< Previous 1 2 3 4 Next   >>|
    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    www无码乱伦| 欧洲精品无码一区二区三区在线播放| 中文字幕日韩在线| 2021无码最新国产在线观看| 亚洲中文字幕无码专区| 中文字幕乱偷无码AV先锋| 精品国产一区二区三区无码| 少妇性饥渴无码A区免费 | 精品亚洲成A人无码成A在线观看| 在线观看无码AV网站永久免费| 免费人妻无码不卡中文字幕系| 免费无码一区二区三区蜜桃| 视频二区中文字幕| 一本一道AV无码中文字幕| 亚洲中久无码不卡永久在线观看| 无码国产精品一区二区免费vr| 亚洲国产综合精品中文字幕| 激情欧美一区二区三区中文字幕| 亚洲一区无码精品色| 亚洲av无码专区在线观看素人| 国产精品无码专区| 精品无码av一区二区三区| 色综合久久无码五十路人妻| 日韩国产成人无码av毛片| 亚洲A∨无码无在线观看| 亚洲乱码无码永久不卡在线| 中文字幕久久精品无码| 国产色爽免费无码视频| 中文字幕无码日韩专区| 亚洲中文字幕无码日韩| 无码中文字幕日韩专区视频| 成人午夜精品无码区久久| 亚洲一区精品无码| 亚洲熟妇无码八AV在线播放| 亚洲国产精品无码久久久秋霞2 | 亚洲Av综合色区无码专区桃色| 中文字幕无码乱人伦| 亚洲AV无码一区二区二三区入口 | 日韩精品无码一本二本三本| 无码国内精品人妻少妇蜜桃视频| 日韩人妻无码一区二区三区久久|